0

    524506

    CORALAB

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    CORAL LABORATORIES LTD. Share Price Today

    Investment Returns

    Over 1 Month 18.29% Over 3 Months 38.50% Over 6 Months 32.46% Over 1 Year -0.84%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    CORAL LABORATORIES LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 217.40
    • P/E Ratio (TTM) 12.99
    • Beta 0.24
    • Book Value / share 585.74
    • Return on equity 12.76%
    • EPS (TTM) 45.27
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 5.22
    info icon alternate text

    CORAL LABORATORIES LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 26.48
    Operating Expense 20.83
    Net Profit 5.22
    Net Profit Margin (%) 19.71
    Earnings Per Share (EPS) 14.62
    EBITDA 8.84
    Effective Tax Rate (%) 36.91
    Particulars DEC 2025 (Values in Cr)
    Revenue 21.56
    Operating Expense 20.36
    Net Profit 2.78
    Net Profit Margin (%) 12.89
    Earnings Per Share (EPS) 7.77
    EBITDA 4.39
    Effective Tax Rate (%) 24.86
    Particulars SEP 2025 (Values in Cr)
    Revenue 19.03
    Operating Expense 14.65
    Net Profit 5.82
    Net Profit Margin (%) 30.58
    Earnings Per Share (EPS) 16.29
    EBITDA 7.97
    Effective Tax Rate (%) 21.56
    Particulars JUN 2025 (Values in Cr)
    Revenue 18.82
    Operating Expense 17.15
    Net Profit 2.56
    Net Profit Margin (%) 13.60
    Earnings Per Share (EPS) 7.18
    EBITDA 4.23
    Effective Tax Rate (%) 31.18
    Particulars MAR 2025 (Values in Cr)
    Revenue 28.13
    Operating Expense 26.00
    Net Profit 2.83
    Net Profit Margin (%) 10.06
    Earnings Per Share (EPS) 7.91
    EBITDA 4.40
    Effective Tax Rate (%) 26.49
    Particulars MAR 2026 (Values in Cr)
    Revenue 85.90
    Operating Expense 72.99
    Net Profit 16.38
    Net Profit Margin (%) 19.06
    Earnings Per Share (EPS) 45.85
    EBITDA 25.42
    Effective Tax Rate (%) 29.12
    Particulars MAR 2025 (Values in Cr)
    Revenue 115.01
    Operating Expense 90.88
    Net Profit 24.16
    Net Profit Margin (%) 21.00
    Earnings Per Share (EPS) 67.61
    EBITDA 34.58
    Effective Tax Rate (%) 25.59
    Particulars MAR 2024 (Values in Cr)
    Revenue 83.66
    Operating Expense 69.40
    Net Profit 15.79
    Net Profit Margin (%) 18.87
    Earnings Per Share (EPS) 44.19
    EBITDA 22.71
    Effective Tax Rate (%) 23.83
    Particulars MAR 2023 (Values in Cr)
    Revenue 78.12
    Operating Expense 76.83
    Net Profit 6.45
    Net Profit Margin (%) 8.25
    Earnings Per Share (EPS) 18.04
    EBITDA 10.75
    Effective Tax Rate (%) 21.62
    Particulars MAR 2022 (Values in Cr)
    Revenue 75.61
    Operating Expense 69.53
    Net Profit 9.05
    Net Profit Margin (%) 11.96
    Earnings Per Share (EPS) 25.32
    EBITDA 13.99
    Effective Tax Rate (%) 23.69
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 563.19
    ROE % 12.76
    ROCE % 16.98
    Total Debt to Total Equity 0.01
    EBITDA Margin 30.07
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 496.83
    ROE % 9.50
    ROCE % 12.26
    Total Debt to Total Equity 0.00
    EBITDA Margin 27.15
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 433.29
    ROE % 4.15
    ROCE % 5.23
    Total Debt to Total Equity 0.02
    EBITDA Margin 13.76
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 436.81
    ROE % 6.18
    ROCE % 7.70
    Total Debt to Total Equity 0.04
    EBITDA Margin 18.50
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 382.48
    ROE % 10.74
    ROCE % 13.28
    Total Debt to Total Equity 0.05
    EBITDA Margin 20.34
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 79.86
    Total Assets 229.46
    Total Liabilities 229.46
    Total Equity 201.20
    Share Outstanding 0
    Price to Book Ratio 1.25
    Return on Assets (%) 10.52
    Return on Capital (%) 11.8
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 61.28
    Total Assets 205.68
    Total Liabilities 205.68
    Total Equity 177.49
    Share Outstanding 0
    Price to Book Ratio 0.75
    Return on Assets (%) 7.67
    Return on Capital (%) 8.9
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 40.40
    Total Assets 174.34
    Total Liabilities 174.34
    Total Equity 154.79
    Share Outstanding 0
    Price to Book Ratio 0.53
    Return on Assets (%) 3.69
    Return on Capital (%) 4.16
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 37.47
    Total Assets 189.89
    Total Liabilities 189.89
    Total Equity 156.05
    Share Outstanding 0
    Price to Book Ratio 0.58
    Return on Assets (%) 4.76
    Return on Capital (%) 5.58
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 34.82
    Total Assets 167.53
    Total Liabilities 167.53
    Total Equity 136.64
    Share Outstanding 0
    Price to Book Ratio 0.84
    Return on Assets (%) 8.09
    Return on Capital (%) 9.49
    Particulars MAR 2025 (Values in Cr)
    Net Income 33.23
    Cash from Operations 6.10
    Cash from Investing -0.15
    Cash from Financing 2.70
    Net change in Cash 1.33
    Free Cash Flow 6.57
    Particulars MAR 2024 (Values in Cr)
    Net Income 20.89
    Cash from Operations -0.57
    Cash from Investing 1.39
    Cash from Financing 0.00
    Net change in Cash -4.05
    Free Cash Flow 0.41
    Particulars MAR 2023 (Values in Cr)
    Net Income 8.18
    Cash from Operations 14.63
    Cash from Investing -2.61
    Cash from Financing -6.42
    Net change in Cash 3.62
    Free Cash Flow 16.57
    Particulars MAR 2022 (Values in Cr)
    Net Income 10.89
    Cash from Operations 10.45
    Cash from Investing -6.05
    Cash from Financing 0.14
    Net change in Cash 0.18
    Free Cash Flow 16.00
    Particulars MAR 2021 (Values in Cr)
    Net Income 17.59
    Cash from Operations 4.35
    Cash from Investing -0.06
    Cash from Financing 0.35
    Net change in Cash 1.21
    Free Cash Flow 5.71
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD. 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 431.50 19.03 3.12 1269.95 256.40 480.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2455.05 43.22 18.34 41590.03 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD 482.50 52.16 4.42 5117.21 118.35 552.90

    CORAL LABORATORIES LTD. shareholding pattern

    Holding
    28.48%
    71.51%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    CORAL LABORATORIES LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    609.00 2.19 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 598.90
    • 26 Days 578.00
    • 10 Days 598.60
    • 50 Days 543.10
    • 12 Days 597.40
    • 100 Days 508.00
    • 20 Days 587.60
    • 200 Days 509.10
    593.95 PIVOT
    First Support 586.95 First Resistance 602.90 Second Support 578.00 Second Resistance 609.90 Third Support 571.00 Third Resistance 618.85
    RSI 56.77 ADX 29.47 MACD 19.38 Williams % R -67.86 Commodity Channel Index (CCI) -58.27
    Date 2026-07-17 Week 484.00 Same Day 123.00 Month 1760.00
    1 Year 0.25 3 Year 0.68
    Over 1 Month
    18.29% down
    Over 1 Year
    -0.84% down
    Over 3 Months
    38.50% down
    Over 3 Years
    34.08% down
    Over 6 Months
    32.46% down
    Over 5 Years
    7.19% down

    CORAL LABORATORIES LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    19 Sep 2025 1.5 Final 19 Sep 2025 Equity shares
    20 Sep 2024 2.0 Final 21 Sep 2024 Equity shares
    19 Sep 2019 2.0 Final 21 Sep 2019 Equity shares
    18 Sep 2018 2.0 Final 21 Sep 2018 Equity shares
    11 Sep 2017 5.0 Final 13 Sep 2017 Equity shares
    16 Sep 2016 3.0 Final 20 Sep 2016 Equity shares
    08 Sep 2015 2.5 Final 10 Sep 2015 Equity shares
    16 Sep 2014 2.0 Final 18 Sep 2014 Equity shares
    18 Sep 2013 1.5 Final 20 Sep 2013 Equity shares
    17 Sep 2012 1.5 Final 19 Sep 2012 Equity shares
    19 Sep 2011 1.5 Final 21 Sep 2011 Equity shares
    17 Sep 2010 1.5 Final 21 Sep 2010 Equity shares
    17 Sep 2009 1.2 Final 22 Sep 2009 Equity shares
    19 Sep 2008 1.0 Final 23 Sep 2008 Equity shares
    20 Sep 2007 1.5 Final 24 Sep 2007 Equity shares
    20 Sep 2005 0.0 Final 22 Sep 2005 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Coral Laboratories Ltd?

    Answer Field

    Coral Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 609.00 as on Jul 20 2026 11:58 AM.

    What is the Market Cap of Coral Laboratories Ltd Share?

    Answer Field

    The market cap of Coral Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 217.40 as on Jul 20 2026 11:58 AM.

    What is the 52 Week High and Low of Coral Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Coral Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 659.00 and ₹ 360.00.

    What is 1 year return for Coral Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been -0.84%.

    What is the P/E Ratio of Coral Laboratories Ltd Share?

    Answer Field

    As on Jul 20 2026 11:58 AM the price-to-earnings (PE) ratio for Coral Laboratories Ltd share is 12.99.

    What is the PB ratio of Coral Laboratories Ltd Share?

    Answer Field

    As on Jul 20 2026 11:58 AM, the price-to-book (PB) ratio for Coral Laboratories Ltd share is 585.74.

    How to Buy Coral Laboratories Ltd Share?

    Answer Field

    You can trade in Coral Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Coral Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Coral Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Coral Laboratories Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |